Literature DB >> 12956878

Roles of HLA-B, HLA-C and HLA-DPA1 incompatibilities in the outcome of unrelated stem-cell transplantation.

M Schaffer1, A Aldener-Cannavá, M Remberger, O Ringdén, O Olerup.   

Abstract

In unrelated stem-cell transplantation, the value of matching at the HLA-A, -B and -DR loci between donor and recipient is well documented. The effect of HLA-C, DPB1 and DPA1 mismatches on transplantation outcome is unclear. In this study, 104 donor recipient-pairs, transplanted at Huddinge University Hospital between 1988 and 1999, were retrospectively HLA class I- and class II-typed by PCR-SSP. The samples were typed for HLA-A, -B and -C and HLA-DRB1, -DRB3, -DRB4, -DRB5, -DQA1, -DQB1, -DPB1 and -DPA1 with allele level resolution. Isolated HLA-B allele level mismatches were associated with an increased incidence of acute graft versus host disease grades II-IV and grades III-IV. HLA-C-mismatched, but killer cell immunoglobulin-like receptor (KIR) ligand motif-matched stem-cell grafts were significantly associated with improved survival rates and relapse-free survival (RFS). In patients receiving HLA-DPA1-mismatched stem cell grafts, reduced survival and shorter RFS were seen. These patients also had an increased frequency of relapses (64%vs 26%). We conclude that genomic HLA class I- and class II-typing may improve the outcome after unrelated stem-cell transplantation. The awareness of HLA class I- and II-mismatches in a recipient-donor pair makes it possible to give appropriate pre- and post-transplantation treatment.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12956878     DOI: 10.1034/j.1399-0039.2003.00089.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  15 in total

1.  Is there any impact of HLA-DPB1 disparity in 10/10 HLA-matched unrelated hematopoietic SCT? Results of a French multicentric retrospective study.

Authors:  K Gagne; P Loiseau; V Dubois; F Dufossé; P Perrier; A Dormoy; I Jollet; V Renac; D Masson; C Picard; X Lafarge; D Hanau; F Quainon; F Delbos; B Coeffic; Léna Absi; J-F Eliaou; V Moalic; M Fort; M de Matteis; I Theodorou; F Hau; A Batho; B Pedron; S Caillat-Zucman; E Marry; N Raus; I Yakoub-Agha; A Cesbron
Journal:  Bone Marrow Transplant       Date:  2014-11-03       Impact factor: 5.483

2.  Cytokine levels following allogeneic hematopoietic cell transplantation: a match-pair analysis of home care versus hospital care.

Authors:  Olle Ringdén; Mats Remberger; Johan Törlén; Sigrun Finnbogadottir; Britt-Marie Svahn; Behnam Sadeghi
Journal:  Int J Hematol       Date:  2021-02-05       Impact factor: 2.490

3.  Long-term outcome in patients treated at home during the pancytopenic phase after allogeneic haematopoietic stem cell transplantation.

Authors:  Olle Ringdén; Behnam Sadeghi; Gianluca Moretti; Sigrun Finnbogadottir; Brita Eriksson; Jonas Mattsson; Britt-Marie Svahn; Mats Remberger
Journal:  Int J Hematol       Date:  2017-11-15       Impact factor: 2.490

4.  C-reactive protein levels before reduced-intensity conditioning predict outcome after allogeneic stem cell transplantation.

Authors:  Mats Remberger; Jonas Mattsson
Journal:  Int J Hematol       Date:  2010-06-25       Impact factor: 2.490

5.  Characterization of long-term mixed donor-donor chimerism after double cord blood transplantation.

Authors:  J Gertow; S Berglund; M Okas; M Uzunel; L Berg; K Kärre; J Mattsson; M Uhlin
Journal:  Clin Exp Immunol       Date:  2010-08-20       Impact factor: 4.330

6.  Hematopoietic SCT: a useful treatment for late metachromatic leukodystrophy.

Authors:  M Solders; D A Martin; C Andersson; M Remberger; T Andersson; O Ringdén; G Solders
Journal:  Bone Marrow Transplant       Date:  2014-05-05       Impact factor: 5.483

7.  Lymphocyte recovery is a major determinant of outcome after matched unrelated myeloablative transplantation for myelogenous malignancies.

Authors:  Katarina Le Blanc; A John Barrett; Marie Schaffer; Hans Hägglund; Per Ljungman; Olle Ringdén; Mats Remberger
Journal:  Biol Blood Marrow Transplant       Date:  2009-09       Impact factor: 5.742

8.  Stable mixed donor-donor chimerism after double cord blood transplantation.

Authors:  Sofia Berglund; Mantas Okas; Jens Gertow; Michael Uhlin; Jonas Mattsson
Journal:  Int J Hematol       Date:  2009-08-22       Impact factor: 2.490

9.  Reduced intensity conditioning and oral care measures prevent oral mucositis and reduces days of hospitalization in allogeneic stem cell transplantation recipients.

Authors:  Karin Garming Legert; Mats Remberger; Olle Ringdén; Anders Heimdahl; Göran Dahllöf
Journal:  Support Care Cancer       Date:  2014-03-20       Impact factor: 3.603

10.  Role of HLA in Hematopoietic Stem Cell Transplantation.

Authors:  Meerim Park; Jong Jin Seo
Journal:  Bone Marrow Res       Date:  2012-10-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.